Cranberry Capsules Market Size to Hit USD 2.94 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cranberry Capsules Market

5.1. COVID-19 Landscape: Cranberry Capsules Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cranberry Capsules Market, By Formulation Type

8.1. Cranberry Capsules Market Revenue and Volume, by Formulation Type

8.1.1. Pure Cranberry Extract Capsules

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Cranberry + Probiotic Blend Capsules

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Cranberry + Vitamin Blend Capsules

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Cranberry + Herbal Blend Capsules

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Cranberry Capsules Market, By Dosage Strength (per capsule)

9.1. Cranberry Capsules Market Revenue and Volume, by Dosage Strength (per capsule)

9.1.1. Low-dose (≤ 150 mg)

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Mid-dose (151 – 300 mg)

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. High-dose (301 – 500 mg)

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Ultra-high-dose (> 500 mg)

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Cranberry Capsules Market, By Extract Type

10.1. Cranberry Capsules Market Revenue and Volume, by Extract Type

10.1.1. Standardized Proanthocyanidin (PAC) Extract

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Whole-Fruit Extract

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Freeze-dried Powder

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Concentrated Juice Extract

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Cranberry Capsules Market, By Target Consumer Segment

11.1. Cranberry Capsules Market Revenue and Volume, by Target Consumer Segment

11.1.1. Women (UTI-oriented health)

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. General Adult (general antioxidant)

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Seniors (age 60+)

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Athletes/Fitness-oriented

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Cranberry Capsules Market, By Distribution Channel

12.1. Cranberry Capsules Market Revenue and Volume, by Distribution Channel

12.1.1. Pharmacy/Retail Health Stores

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Online Direct-to-Consumer

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. E-Commerce Marketplaces

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Hospital/Clinic Channel

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Cranberry Capsules Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Formulation Type

13.1.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.1.3. Market Revenue and Volume Forecast, by Extract Type

13.1.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.1.5. Market Revenue and Volume Forecast, by Distribution Channel

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Formulation Type

13.1.6.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.1.6.3. Market Revenue and Volume Forecast, by Extract Type

13.1.6.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.1.6.5. Market Revenue and Volume Forecast, by Distribution Channel

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Formulation Type

13.1.7.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.1.7.3. Market Revenue and Volume Forecast, by Extract Type

13.1.7.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.1.7.5. Market Revenue and Volume Forecast, by Distribution Channel

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Formulation Type

13.2.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.2.3. Market Revenue and Volume Forecast, by Extract Type

13.2.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.2.5. Market Revenue and Volume Forecast, by Distribution Channel

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Formulation Type

13.2.6.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.2.6.3. Market Revenue and Volume Forecast, by Extract Type

13.2.7. Market Revenue and Volume Forecast, by Target Consumer Segment

13.2.8. Market Revenue and Volume Forecast, by Distribution Channel

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Formulation Type

13.2.9.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.2.9.3. Market Revenue and Volume Forecast, by Extract Type

13.2.10. Market Revenue and Volume Forecast, by Target Consumer Segment

13.2.11. Market Revenue and Volume Forecast, by Distribution Channel

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Formulation Type

13.2.12.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.2.12.3. Market Revenue and Volume Forecast, by Extract Type

13.2.12.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.2.13. Market Revenue and Volume Forecast, by Distribution Channel

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Formulation Type

13.2.14.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.2.14.3. Market Revenue and Volume Forecast, by Extract Type

13.2.14.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.2.15. Market Revenue and Volume Forecast, by Distribution Channel

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Formulation Type

13.3.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.3.3. Market Revenue and Volume Forecast, by Extract Type

13.3.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.3.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Formulation Type

13.3.6.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.3.6.3. Market Revenue and Volume Forecast, by Extract Type

13.3.6.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.3.7. Market Revenue and Volume Forecast, by Distribution Channel

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Formulation Type

13.3.8.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.3.8.3. Market Revenue and Volume Forecast, by Extract Type

13.3.8.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.3.9. Market Revenue and Volume Forecast, by Distribution Channel

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Formulation Type

13.3.10.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.3.10.3. Market Revenue and Volume Forecast, by Extract Type

13.3.10.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Formulation Type

13.3.11.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.3.11.3. Market Revenue and Volume Forecast, by Extract Type

13.3.11.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Formulation Type

13.4.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.4.3. Market Revenue and Volume Forecast, by Extract Type

13.4.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.4.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Formulation Type

13.4.6.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.4.6.3. Market Revenue and Volume Forecast, by Extract Type

13.4.6.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.4.7. Market Revenue and Volume Forecast, by Distribution Channel

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Formulation Type

13.4.8.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.4.8.3. Market Revenue and Volume Forecast, by Extract Type

13.4.8.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.4.9. Market Revenue and Volume Forecast, by Distribution Channel

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Formulation Type

13.4.10.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.4.10.3. Market Revenue and Volume Forecast, by Extract Type

13.4.10.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Formulation Type

13.4.11.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.4.11.3. Market Revenue and Volume Forecast, by Extract Type

13.4.11.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Formulation Type

13.5.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.5.3. Market Revenue and Volume Forecast, by Extract Type

13.5.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.5.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Formulation Type

13.5.6.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.5.6.3. Market Revenue and Volume Forecast, by Extract Type

13.5.6.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.5.7. Market Revenue and Volume Forecast, by Distribution Channel

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Formulation Type

13.5.8.2. Market Revenue and Volume Forecast, by Dosage Strength (per capsule)

13.5.8.3. Market Revenue and Volume Forecast, by Extract Type

13.5.8.4. Market Revenue and Volume Forecast, by Target Consumer Segment

13.5.8.5. Market Revenue and Volume Forecast, by Distribution Channel

Chapter 14. Company Profiles

14.1. NOW Foods

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Puritan’s Pride

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Solaray

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Life Extension

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. BioSchwartz

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. NutraPro

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Pure Encapsulations

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Natrol

14.8.1. Company OverviewÄ

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Evalar

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Healthy Origins

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The cranberry capsules market size is expected to increase from USD 1.25 billion in 2024 to USD 2.94 billion by 2034.

The cranberry capsules market is expected to grow at a compound annual growth rate (CAGR) of around 8.94% from 2025 to 2034.

The major players in the cranberry capsules market include Nature’s Bounty, NOW Foods, GNC, Puritan’s Pride, Swanson Health Products, Solaray, Jarrow Formulas, Gaia Herbs, Cranberry King (e.g., Swanson), Nature’s Way, Carlson Labs, Life Extension, Oregon’s Wild Harvest, BioSchwartz, NutraPro, Pure Encapsulations, Natrol, Evalar, Healthy Origins, and Schiff (Blackmores Group).

The driving factors of the cranberry capsules market are due to rising consumer awareness of its benefits in supporting urinary tract health and overall wellness.

North America region will lead the global cranberry capsules market during the forecast period 2025 to 2034.